Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion type Assertion NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_head.
- NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_provenance.
- NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion evidence source_evidence_literature NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_provenance.
- NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion SIO_000772 16988840 NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_provenance.
- NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion wasDerivedFrom befree-20140225 NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_provenance.
- NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_assertion wasGeneratedBy ECO_0000203 NP650262.RA-QYTw9WRp59lZUw4lbSj6dpJ7ANmCtqAziCgnC19RAM130_provenance.